Glaucoma: When to Escalate or Refer

Though most people with glaucoma manage well with an eye drop or two and retain their functional vision, a subgroup of glaucoma patients worsen catastrophically over time. Is it possible to identify which group your glaucoma patients will be in? And when should the comprehensive ophthalmologist consider escalation or referral to a glaucoma specialist? Drs. Aakriti Shukla and Sean Rivera join host Andrew Pouw to look at the data and discuss strategies that work across various practice settings and patient populations.

For all episodes or to claim CME credit for selected episodes, visit www.aao.org/podcasts.

CME Information

Release: April 20, 2023; expires April 20, 2026

Disclosures: 
Planner/Faculty: Dr. Pouw reports no relevant financial disclosures.
Faculty: Drs. Rivera and Shukla report no relevant financial disclosures.
Review Panel: Dr. Mazeyar Saboori receives consulting and lecture fees from Aerie Pharmaceuticals. The following reviewers report no financial disclosures: Jeffrey D. Henderer, MD; Danah Albreiki, MBBS; Ashiyani Nariani, MD, MPH; Annie Moreau, MD; and Allison Umfress, MD.

Learning Objective: Upon completion of this episode, the listener should be able to describe a strategy for how to escalate care in glaucoma patients and whether to refer to a glaucoma specialist.

Audience: This activity is intended for comprehensive ophthalmologists.

Accreditation: The American Academy of Ophthalmology is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The American Academy of Ophthalmology designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credits^TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Hardware/Software Requirements: This learning activity requires a current web browser and speaker or headset capable of playing streaming audio.